Skip to main content
. 2021 Aug 22;36(11):2177–2183. doi: 10.1002/jbmr.4419

Table 1.

Descriptive Characteristics of the Overall 1:1 Matched Cohort

Characteristic N‐BPs untreated cohort N‐BPS treated cohort
n 63,185 63,185
Age (years), mean ± SD 73.4 ± 10.7 73.4 ± 10.7
Male, n (%) 4507 (7.1) 4507 (7.1)
Respiratory drugs, n (%) 14321 (22.7) 14321 (22.7)
Respiratory hospitalization, n (%) 5628 (8.9) 5628 (8.9)
Neoplasms, n (%) 4918 (7.8) 4918 (7.8)
CV hospitalization, n (%) 11704 (18.5) 11704 (18.5)
Antihypertensives, n (%) 41804 (66.2) 41804 (66.2)
Statins, n (%) 23830 (37.7) 23830 (37.7)
Antidiabetics, n (%) 7376 (11.7) 7376 (11.7)
Antidepressants, n (%) 11923 (18.9) 11923 (18.9)
Glucocorticoids, n (%) 17950 (28.4) 17950 (28.4)
Other anti‐osteoporotic drugs, n (%) 696 (1.1) 696 (1.1)

Antidiabetics included insulin treatment.

CV = cardiovascular; N‐BPs = amino‐bisphosphonates.